ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AZN Astrazeneca Plc

11,352.00
84.00 (0.75%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  84.00 0.75% 11,352.00 11,350.00 11,352.00 11,412.00 11,288.00 11,288.00 3,579,740 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 29.55 175.98B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 11,268p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,348.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £175.98 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 29.55.

Astrazeneca Share Discussion Threads

Showing 4751 to 4772 of 6150 messages
Chat Pages: Latest  198  197  196  195  194  193  192  191  190  189  188  187  Older
DateSubjectAuthorDiscuss
09/4/2021
17:50
Still no herd immunity in Manaus Brazil, eventhough it was suggested that
milestone had been reached late last year - so either wanning immunity, reinfections
with a new variant (P1) or an overestimating of the numbers who would be immune
by late 2020 - perhaps an element of all 3.

Israel data looks very positive as does the UK, vaccination clearly working.
The key is can we prevent mass new variant reinfections and if people get
reinfected could previous infection/existing vaccines mitigate more serious cases.

Even If millions get reinfected, but with mild or asymptomatic cases, then
we can still pretty much return to normal.


BMJ article on Brazil:

essentialinvestor
09/4/2021
16:55
It'll take forever to reach herd immunity that way, EI.

Why they don't they go door to door..?

blusteradjuster
09/4/2021
16:02
* Human trials at the Royal Free in Hampstead where healthy volunteers are
intentionally infected with the virus.

It was cleared by the ethics committee back in February so may now be underway.

essentialinvestor
09/4/2021
15:53
Don't know why the EMA don't just approve a blast of SARS-CoV-2 up the nose and be done with it.
blusteradjuster
09/4/2021
15:38
Have the Americans been hiding their data?
raydxx
09/4/2021
15:34
J&J uses the same delivery mechanism as the AZN vaccine I read somewhere. I also read there are Pfizer cases too. Lots of noise. Lots of lobbying going on.
minerve 2
09/4/2021
15:31
The European Medicines Agency said on Friday that it has started a review to assess blood clots in people who received Johnson & Johnson’s Covid-19 vaccine.

Bloomberg reported that four serious cases of rare clots accompanied by low blood platelets, one of which was fatal, have emerged after vaccination with the J&J jab.

The move turns the European regulator's safety scrutiny on a second Covid vaccination, after the Oxford/AstraZeneca jab was possibly linked to a rare blood-clotting disorder.

One of the blood clot cases following the J&J jab happened during a clinical trial. At the time, the company responded saying it had found no evidence the vaccine was at fault.

The three other cases occurred in the United States, where the shot has been given to almost 5 million people.

Though the J&J vaccine is approved in the EU, its rollout in the bloc isn't expected to start until later this month.

However, the EU is relying on the single-shot vaccine to boost its Covid-19 immunization programme amid restrictions in some countries on use of the AstraZeneca jab, which is administered in two doses, for certain age groups.

maxk
09/4/2021
13:07
"one of the benefits of being an adult."

Could be a disadvantage. :)

It depends on the adult.

minerve 2
09/4/2021
12:52
wipo, good for you. It's entirely your own decision,
one of the benefits of being an adult.

essentialinvestor
09/4/2021
12:49
Good post.Hopefully current vaccines will protect us from developing serious illness from new strains.
coxsmn
09/4/2021
12:48
From what I have read so far it does seem that the current AZN vaccine offers reasonable protection against the new variants in SA and Brazil. How long this lasts who knows. Yes, we are fortunate, but for how long.
minerve 2
09/4/2021
12:47
Never had the flu jab and never had the flu, its a money spinner
wipo1
09/4/2021
12:34
M, we can only vaccinate against so many of these variants.
Seasonal flu jab, from memory, targets 3 or 4 strains annually.

For example, if a person was vaccinated against a P1 strain, would
that protect against a similar further mutation, or at least provide
some mitigation against serious illness.

For the time being we are in a fortunate position in the UK.

essentialinvestor
09/4/2021
12:18
North Carolina halting J&J vaccine as a lot of people fainting after receiving the jab

hxxps://www.aol.com/news/north-carolina-sites-halt-j-000205052-081444800.html?soc_src=aolapp

coxsmn
09/4/2021
11:51
At some point I'm assuming statistical data will show other vaccines to have clotting and other side effects. I'm also assuming that mutations and the nature of COVID will demand regular boosters and new vaccines of which AZN will start to charge with profit.
minerve 2
09/4/2021
11:33
On the AZN CEO, disagree he should be a cheerleader for the vaccine,
that's not his role or the role of AstraZeneca.

essentialinvestor
09/4/2021
11:31
Fred, would agree with that as it goes.

What's unfolding in Brazil and the potential for that area to act as a giant
incubator for new variants may be significantly underestimated.

Average age of ICU patients in some regions of Brazil is now in to the 50's.

essentialinvestor
09/4/2021
03:42
Stop talking rubbish it's total exaggeration. There is no way to prove symptoms are caused by a virus
wipo1
09/4/2021
00:58
I remember seeing images of people collapsing in streets this time last year, yet still see average age of covid death in the 80s so still don’t understand the hysteria.
lendmeafiver
09/4/2021
00:47
The alternative maxk , was to have vaccinated children instead of leaving them unprotected and vulnerable

Disgusting

They should have been number one on the list

buywell2
09/4/2021
00:22
'AstraZeneca chief must do more to defend vaccine, says investor'

Pascal Soriot’s decision to stay in Australia with his family “did not give right signal or message”, says EdenTree Investment Management

philanderer
08/4/2021
23:30
What is the alternative, lockdown forever?
maxk
Chat Pages: Latest  198  197  196  195  194  193  192  191  190  189  188  187  Older

Your Recent History

Delayed Upgrade Clock